Magellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017
|
|
- Edith Webster
- 6 years ago
- Views:
Transcription
1 Magellan Health Cantor Fitzgerald Healthcare Conference September 26, 2017
2 Cautionary Statement and Non-GAAP measures 2 This slide presentation and our accompanying oral comments include forward-looking statements contemplated under the Private Securities Litigation Reform Act of These forward-looking statements are based on management s current expectations and are subject to known and unknown uncertainties and risks which could cause actual results to differ materially from those reflected, contemplated or implied by such forward-looking statements including, but not limited to, the following: Termination or non-renewal of contracts by customers Renegotiation of rates paid to and/or by the Company by customers and/or providers Higher utilization of health treatment services by members Delays, higher costs or inability to implement the Company s initiatives The impact of new or amended laws or regulations Acts of war, terrorism or other catastrophic events The impact of increased competition on ability to maintain or obtain contracts The impact of increased competition on rates paid to or by the Company Loss of relationships with providers, vendors and/or manufacturers The impact of share repurchase programs Governmental inquiries and/or litigation Interest rate changes Economic uncertainties Many of these factors are beyond the control of the Company. Any and all forward-looking statements made in this presentation are qualified in their entirety by the complete discussion of risks set forth under the caption Risk Factors in Magellan s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission on February 24, 2017, and the company s subsequent Quarterly Reports on Form 10-Q filed during Magellan undertakes no obligation to update any forward-looking or cautionary statements. The Company reports its financial results in accordance with GAAP, however the Company s management also assesses business performance and makes business decisions regarding the Company s operations using certain non-gaap measures. A reconciliation of GAAP to non-gaap measures is included at the end of this presentation as well as our SEC filings.
3 Magellan Health Today: At a Glance Revenue Breakdown (2016) Key Metrics 2016 Revenue ~$5B Pharmacy 46% Healthcare 54% Market cap Material contracts up for renewal prior to 2019 ~$1.9B None Contracts representing > 15% of revenue None 3
4 Agenda At an Inflection Point Two Growth Platforms The Road Ahead 4
5 A Repositioned Company, At an Inflection Point Successfully Repositioned Two Growth Platforms Long-Term Sustained Growth Strong performance record, since 2013 grew Pharmacy >3X Both with a specialty focus and multiple drivers Our unique capabilities play key role in reducing healthcare costs 5
6 Repositioned for Growth Diversification Building on behavioral health Repositioning Through Magellan Complete Care & Pharmacy expansion Growing Through two platforms Healthcare and Pharmacy 6
7 Capital Deployed Strategically to Support Repositioning ~$1.5B of Cash Deployed ~$260M Capital Expenditures ~$85M Operational Investments ~$610M* M&A ~$570M Returned to Shareholders High-return investments Investments in MCC and Pharmacy 9 acquisitions ~9.9M shares repurchased 7 * Excludes approximately $80M in stock compensation related to acquisitions
8 R E S U L T S : Solid Track Record of Growth while Repositioning Revenues $B ~11% CAGR $4.6 $4.8 $3.5 $3.8 54% Healthcare % of Total 82% 46% 18% Pharmacy % of Total Growth achieved despite legacy business losses, and remaining large contract exposure minimized 8
9 R E S U L T S : At an Inflection Point Positioned for Long-Term Sustainable Growth Revenue ($Billions) Segment Profit 1 ($Millions) $3.5 $3.8 $4.6 $ $4.8 $259 $267 $329-$349 $302 $ E E 9 1 represents an adjusted financial measure not in accordance with GAAP. The reconciliation of this measure as well as Management s explanation for its use can be found in GAAP to Non-GAAP Measures section at the end of this presentation.
10 Agenda At an Inflection Point Two Growth Platforms The Road Ahead 10
11 Our Two Growth Platforms 11
12 Magellan Healthcare Has Built a Leadership Position in Complex Population Health 40+ years experience 50M 1k+ lives contracts Specialty Innovators Advanced imaging Cardiac MSK pain management Physical Medicine Federal / Military Full-service Managed Care Organization AlphaCare New York TMG Wisconsin MCC Florida MCC Virginia 12 Behavioral Health Pioneers Autism Opioid Cobalt digital therapy
13 T H E B U S I N E S S A T A G L A N C E Delivering Differentiated Services to Complex Populations Healthcare Revenues (~$3B) Behavioral Health Specialty Federal 42% 83% 21% 9% 27% 13% 3% Behavioral Health Specialty Federal Fast Growing Magellan Complete Care Strategically diversified revenue Magellan Complete Care provides key growth driver Targeted acquisitions provides growth opportunities New growth offsets Government behavioral health contract losses Reduced contract risk and increase in growth businesses 13
14 Core Capabilities Delivered Across All Buyer Segments VALUE PROPOSITION Complex Population Management Behavioral, Specialty, MCO Evidence based, clinically driven, self-directed care Analytics, technology, performance Lower cost, better outcomes Payer Agnostic Diverse Payment Arrangements Differentiated Model 14
15 Our Two Growth Platforms 15
16 T H E B U S I N E S S A T A G L A N C E Full Service PBM Focused on High-Growth Specialty Drug Spend Full service PBM plus differentiated specialty capabilities Revenues ($Billion) #1 in U.S. focused on medical pharmacy management ~14M lives 4 acquisitions last 4 years, fueling 50% of growth $1.1 ~48% CAGR $1.7 ~$2.3 $
17 Magellan Rx A Full-Service PBM Across the U.S. 40+ yrs Medicaid Pharmacy Experience yrs Self-Funded Employer Experience States and D.C. with Commercial PBM States and D.C. with FFS Medicaid PBA States and D.C. with Medicare PDP M ~14M Health Plan Clients Commercial PBM Members Medical Pharmacy Members 17
18 Powerful Pharmacy Trends, Driven by Specialty Drugs $299B $412B $572B Specialty Drugs Traditional Drugs Net promoter scores for PBMs are low Consumerism on the rise Overall drug costs continue to grow Specialty drugs as a percent of total drug spend continues to increase Source: The 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, Drug Channels Institute, 2017, Exhibit 66.
19 But Something is Missing Medical Pharmacy Not managed by most PBMs Specialty Drugs on the medical benefit For every $1 spent on Specialty Drugs under the pharmacy benefit, there is another $1 spent on the medical benefit 25 specialty approvals last year, 50% on medical benefit Specialty Drugs on the pharmacy benefit 28 unique billion-dollar medical pharmacy drugs by Source: The 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, Drug Channels Institute, 2017, Exhibit 66.
20 Agenda At an Inflection Point Two Growth Platforms The Road Ahead 20
21 Well Positioned to Succeed in Current Healthcare Environment Key Trends Focus by government and private payers on managing complex populations Growing awareness that behavioral health, especially severe mental illness, drives significant expenditures Need to manage high-cost specialty drugs, especially in Medicaid and Medicare Opportunity for nimble, entrepreneurial players in a continuing period of transformation Play to Magellan strengths 21
22 Capital Flexibility to Fund Growth Debt Capacity $M Capital Highlights June 30, 2017 $ x TTM EBITDA $600 $400 Additional Net Debt Capacity 1.4 x TTM EBITDA Unrestricted Cash and Investments: $273M Unused Credit Facilities: $223M $200 Actual Net Debt Debt & Capital Lease Obligations: $631M $- 30-Jun-17 Unused 2015 Share Repurchase Authorization: $69M Currently working on refinancing credit facility to increase capacity and flexibility 22
23 Capital in Action: Acquisition of Senior Whole Health STRATEGIC RATIONALE Highly aligned with Magellan s strategy Core managed care capabilities Geographic expansion Attractive financial profile ANTICIPATED FINANCIAL IMPACT Estimated $0.60 EPS and $1.00 Adjusted EPS accretion Beyond 2018, anticipate synergies of approximately $10M annually 23
24 A Repositioned Company, At an Inflection Point Successfully Repositioned Two Growth Platforms Long-Term Sustained Growth Post-2017 Long-Term Growth Objectives: Revenue 10-15% Segment Profit 1 ~10% Adjusted EPS % 24 1 represents an adjusted financial measure not in accordance with GAAP. The reconciliation of this measure as well as Management s explanation for its use can be found in GAAP to Non-GAAP Measures section at the end of this presentation.
25 Overview of Non- GAAP Measures The Company reports its financial results in accordance with GAAP, however the Company s management also assesses business performance and makes business decisions regarding the Company s operations using certain non-gaap measures. The Company evaluates performance of its segments based on profit or loss from operations before stock compensation expense, depreciation and amortization, interest expense, interest and other income, changes in the fair value of contingent consideration recorded in relation to acquisitions, gain on sale of assets, special charges or benefits, and income taxes ( Segment Profit ). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. In addition to Segment Profit, as defined above, the Company also uses adjusted net income attributable to Magellan Health, Inc. ( Adjusted Net Income ) and adjusted net income per common share attributable to Magellan Health, Inc. on a diluted basis ( Adjusted EPS ). Adjusted Net Income and Adjusted EPS reflect certain adjustments made for acquisitions completed after January 1, 2013 to exclude non-cash stock compensation expense resulting from restricted stock purchases by sellers, changes in the fair value of contingent consideration, amortization of identified acquisition intangibles, as well as impairment of identified acquisition intangibles. The Company believes these non-gaap measures provide a more useful comparison of the Company s underlying business performance from period to period and are more representative of the earnings capacity of the Company. Non-GAAP financial measures we disclose, such as Segment Profit, Adjusted Net Income and Adjusted EPS, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. 25
26 Reconciliation of Non-GAAP Measures Reconciliation of Segment Profit to Income before taxes (in millions) 2017 Guidance Low High Segment Profit $ $ $ $ $ $ Stock compensation expense (21.3) (40.6) (50.4) (37.4) (40.0) (36.0) Changes in fair value of contingent consideration - (6.2) (44.3) 0.1 (2.0) - Impairment of intangible assets (4.8) - - Non-controlling interest segment profit (loss) - (5.1) (2.6) (0.7) - - Depreciation and amortization (72.0) (91.0) (102.9) (106.1) (117.0) (113.0) Interest expense (3.0) (7.4) (6.6) (10.2) (23.0) (13.0) Interest and other income Income before income taxes $ $ $ 71.1 $ $ $
27 Reconciliation of Non-GAAP Measures Reconciliation of Net income attributable to Magellan Health, Inc. to Adjusted Net Income and Adjusted EPS (in millions) Low Guidance 2017 High Net income attributable to Magellan Health, Inc. $ 77.9 $ 90.0 $ Adjusted for acquisitions starting in 2013 Stock compensation expense relating to acquisitions Changes in fair value of contingent consideration (0.1) Amortization of acquired intangibles Impairment of intangible assets, net of non-controlling interest 3.9 Tax impact (16.7) (19.7) (19.7) Adjusted Net Income $ $ $ Weighted average number of common shares outstanding - diluted Adjusted EPS $ 4.53 $ 5.08 $
Magellan Health: Innovating for Profitable Growth. Jefferies 2015 Healthcare Conference June 2, 2015
Magellan Health: Innovating for Profitable Growth Jefferies 2015 Healthcare Conference June 2, 2015 Cautionary Statement The schedules and statements made in this presentation include forward-looking statements
More informationA Unique Vision of Care. Jefferies 2014 Global Healthcare Conference June 3, 2014
A Unique Vision of Care Jefferies 2014 Global Healthcare Conference June 3, 2014 Cautionary Statement The following schedules and statements made in this presentation constitute forward-looking statements
More informationJune Investor Presentation
June 2014 Investor Presentation Safe Harbor Certain statements included herein, including guidance and those that express management's objectives and the strategies to achieve those objectives, as well
More information36 th Annual J.P. Morgan Healthcare Conference January 9, Bruce D. Broussard President & CEO
36 th Annual J.P. Morgan Healthcare Conference January 9, 2018 Bruce D. Broussard President & CEO 0 Cautionary statement This presentation includes forward-looking statements within the meaning of the
More informationFourth Quarter 2018 Earnings Conference Call
Fourth Quarter 2018 Earnings Conference Call Larry Merlo President & Chief Executive Officer Eva Boratto Executive Vice President & Chief Financial Officer February 20, 2019 Cautionary Statement Regarding
More informationCantor Fitzgerald 2017 Global Healthcare Conference. September 26, 2017
Cantor Fitzgerald 2017 Global Healthcare Conference September 26, 2017 Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements
More informationWilliam Blair 35 th Annual Growth Stock Conference. June 9, 2015 NYSE: Q. Copyright 2014 Quintiles
William Blair 35 th Annual Growth Stock Conference June 9, 2015 Copyright 2014 Quintiles NYSE: Q Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking
More informationMagellan Health Reports Second Quarter 2018 Financial Results Lowers 2018 Guidance
NEWS RELEASE Media Contact: Lilly Ackley, ackleyl@magellanhealth.com, (860) 507-1923 Investor Contact: Joe Bogdan, jbogdan@magellanhealth.com, (860) 507-1910 Magellan Health Reports Second Quarter 2018
More information36 th Annual J.P. Morgan Healthcare Conference. January 10, 2018
36 th Annual J.P. Morgan Healthcare Conference January 10, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationRaymond James 37 th Annual Institutional Investors Conference. March 8, 2016
Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,
More informationSecond Quarter 2017 Reconciliation of Non-GAAP Financial Measures
Second Quarter 2017 Reconciliation of Non-GAAP Financial Measures Adjusted Operating Income Reconciliation Adjusted operating income is not a measure of financial performance under generally accepted accounting
More informationDiplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017
Diplomat s Acquisition of LDI Integrated Pharmacy Services Nov. 15, 2017 1 DISCLAIMERS NON-GAAP INFORMATION We define Adjusted EBITDA as net income (loss) before interest expense, income taxes, depreciation
More informationCardinal Health Annual Meeting of Shareholders. George S. Barrett Chairman and Chief Executive Officer November 8, 2017
Cardinal Health Annual Meeting of Shareholders George S. Barrett Chairman and Chief Executive Officer November 8, 2017 Forward-looking statements and GAAP reconciliation This presentation contains forward-looking
More informationXylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016
1 Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016 Forward-Looking Statements This presentation contains information that may constitute forward-looking statements.
More informationPress Release INVESTOR RELATIONS CONTACT: MEDIA CONTACT: Will McDowell 215-761-4198 william.mcdowell2@cigna.com Ellie Polack 860-902-4906 elinor.polack@cigna.com Cigna Delivers Strong 2018 Results as it
More informationSECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017
SECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017 SECOND QUARTER EARNINGS CALL AGENDA CEO Transition Robert Abernathy Chairman Strategic Vision Joe Woody Chief Executive Officer Second Quarter Results and
More informationWellCare to Acquire Meridian
WellCare to Acquire Meridian May 9, 018 Cautionary Statements This presentation contains "forward-looking" statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation
More informationCIGNA CORPORATION INVESTOR PRESENTATION. May 5, Cigna
CIGNA CORPORATION INVESTOR PRESENTATION May 5, 2017 1 Forward looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
More informationFourth Quarter 2016 Earnings Conference Call
Fourth Quarter 2016 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 9, 2017 Revised 2/9 Forward-looking
More informationPolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014
PolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014 PolyOne Corporation Page 1 Forward-Looking Statements In this presentation, statements that
More informationStanding strong for payers and patients
Standing strong for payers and patients Eric Slusser, EVP, Chief Financial Officer Everett Neville, SVP Supply Chain and Specialty B A N K O F A M E R I C A M E R R I L L L Y N C H H E A LTH C A RE CONFERENCE
More informationBERNSTEIN. 34 th Annual Strategic Decisions Conference. David Wichmann, CEO May 31, 2018
BERNSTEIN 34 th Annual Strategic Decisions Conference David Wichmann, CEO May 31, 2018 2018 UnitedHealth Group. All Rights Reserved. UnitedHealth Group is a registered trademark with the U.S. Patent and
More informationCFA Society of Minnesota
CFA Society of Minnesota Intellisight 2018 August 15, 2018 John Penshorn Senior Vice President, UnitedHealth Group Mark Flakne Chief Financial Officer, OptumHealth Tim Noel Chief Financial Officer, UnitedHealthcare
More informationBaird 2018 Global Healthcare Conference. September 5, 2018
Baird 2018 Global Healthcare Conference September 5, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationFourth Quarter 2017 Earnings Conference Call
Fourth Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 8, 2018 Important Information No Offer
More informationCowen and Company 38 th Annual Health Care Conference. March 13, 2018
Cowen and Company 38 th Annual Health Care Conference March 13, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking
More informationWellCare Health Plans, Inc.
WellCare Health Plans, Inc. 2019 Annual December 17, 2018 Cautionary Statements Cautionary Statement Regarding Forward-Looking Statements This presentation contains forward-looking statements that are
More informationN E W S R E L E A S E
N E W S R E L E A S E Investors: Brett Manderfeld John S. Penshorn Media: Tyler Mason Vice President Senior Vice President Vice President 952-936-7216 952-936-7214 424-333-6122 (For Immediate Release)
More informationCardinal Health Reports Second-quarter Results for Fiscal Year 2018
FOR IMMEDIATE RELEASE Media: Ellen Barry Investors: Lisa Capodici (614) 553-3858 (614) 757-5035 ellen.barry@cardinalhealth.com lisa.capodici@cardinalhealth.com Cardinal Health Reports Second-quarter Results
More informationAramark Fourth Quarter & Full Year 2018 Results November 13, 2018
Aramark Fourth Quarter & Full Year 2018 Results November 13, 2018 Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation
More informationEndo Health Solutions
Endo Health Solutions 3Q 2013 Earnings Report and A Compelling Combination: Endo Health Solutions and Paladin Labs November 5, 2013 Offer Language Disclosures This communication is not intended to and
More informationCIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016 o o o
More informationAETNA REPORTS SECOND QUARTER 2009 RESULTS
151 Farmington Avenue Hartford, Conn. 06156 Media Contact: Fred Laberge 860-273-4788 labergear@aetna.com Investor Contact: Jeffrey A. Chaffkin 860-273-7830 chaffkinj@aetna.com News Release AETNA REPORTS
More informationPolyOne Investor Presentation Credit Suisse Boston Basic Materials Conference. June 26, 2013
PolyOne Investor Presentation Credit Suisse Boston Basic Materials Conference June 26, 2013 Forward Looking Statements In this presentation, statements that are not reported financial results or other
More informationReconciliation of Non-GAAP Financial Measures. Adjusted Operating Income Reconciliation
Reconciliation of Non-GAAP Financial Measures Adjusted Operating Income Reconciliation Adjusted operating income is not a measure of financial performance under generally accepted accounting principles
More informationCONSOLIDATED HIGHLIGHTS. Total Revenues $ 10,318 $ 9,960 $ 10,385 $ 20,703 Net Realized Investment Gains Consolidated Operating
Cigna Reports Strong Second Quarter 2017 Results, Raises Outlook BLOOMFIELD, Conn., 04 August, 2017 - Cigna Corporation (NYSE: CI) today reported second quarter 2017 results with strong performance across
More informationPowering healthcare provider success
Powering healthcare provider success Now and in the future Investor Information September 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures
More informationQ Earnings. GAAP to Non-GAAP Reconciliation
Q1 2012 Earnings GAAP to Non-GAAP Reconciliation This presentation contains forward-looking statements relating to, among other things, our outlook for full year 2012 bookings, adjusted EBITDA, stock-based
More informationAmerisourceBergen. CECP CEO Investor Forum Steve Collis, Chairman, President & CEO. February 25, 2019
AmerisourceBergen CECP CEO Investor Forum Steve Collis, Chairman, President & CEO February 25, 2019 Cautionary note regarding forward-looking statements Certain of the statements contained in this presentation
More informationFOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook and Update on Divestiture 2018 Priorities Steve Voskuil Chief Financial Officer
More informationLHC Group and Almost Family: A Leading National Provider of In-Home Healthcare. November 16, 2017
LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare November 16, 2017 Forward-Looking Statements This presentation contains forward looking statements (as defined in the Securities
More informationCIGNA CORPORATION. 37 th Annual J.P. Morgan Healthcare Conference January 7, David Cordani President and Chief Executive Officer
CIGNA CORPORATION 37 th Annual J.P. Morgan Healthcare Conference January 7, 2019 David Cordani President and Chief Executive Officer 2 Forward-looking statements and Non-GAAP measures CAUTIONARY STATEMENT
More informationAllscripts Healthcare Solutions
Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationExpress Scripts Announces 2018 First Quarter Results
Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 investor.relations@express-scripts.com Express Scripts Announces 2018 First Quarter Results ST. LOUIS,
More informationDANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019
DANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019 Forward Looking Statements Statements in this presentation and the accompanying call that are not strictly historical,
More informationJ.P. Morgan 34 th Annual Healthcare Conference -San Francisco- January 11, 2016
J.P. Morgan 34 th Annual Healthcare Conference -San Francisco- January 11, 2016 Forward-Looking Statements During the course of this presentation, we may make projections or other forward-looking statements
More informationEndo International plc
Endo International plc UBS Global Healthcare Conference May 21, 2014 Forward Looking Statements; Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of
More information4th Quarter 2018 Earnings. Investor Presentation February 27, 2019
4th Quarter 2018 Earnings Investor Presentation February 27, 2019 DISCLAIMER Forward Looking Statements This investor presentation contains statements reflecting our views about the future performance
More informationWELLCARE HEALTH PLANS, INC. (Exact name of registrant as specified in its charter)
Section 1: 8-K (8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report
More informationInvestor Presentation. August 2007
Investor Presentation August 2007 Forward-Looking Statement This presentation should be considered forward-looking and is subject to various risk factors and uncertainties. For more information on those
More informationReconciliation of Non-GAAP Items
2016 GUIDANCE CVS Health is providing non-gaap information that excludes certain items because of the nature of these items and the impact they have on the analysis of underlying business performance and
More informationBaird 2017 Global Industrial Conference. Chuck McLaughlin Senior Vice President & CFO
Baird 2017 Global Industrial Conference Chuck McLaughlin Senior Vice President & CFO FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Statements in this presentation that are not strictly historical,
More informationPlease note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the
Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the presentation July 16, 2012 and should not be considered
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Alistair Macdonald Chief Executive Officer January 8, 2019 Forward-Looking Statements, Non-GAAP Financial Measures, and Basis of Financial Presentation Forward-Looking
More informationReconciliation of Non-GAAP Items Required by SEC Rules
2016 ACTUAL RESULTS CVS Health is providing non-gaap information that excludes certain items because of the nature of these items and the impact they have on the analysis of underlying business performance
More informationInvestor Presentation. November 2017
Investor Presentation November 2017 1 Forward Looking Statements This presentation contains statements, estimates, or projections that constitute "forward-looking statements" as defined under U.S. federal
More informationN E W S R E L E A S E
N E W S R E L E A S E Investors: Brett Manderfeld John S. Penshorn Media: Tyler Mason Vice President Senior Vice President Vice President 952-936-7216 952-936-7214 424-333-6122 (For Immediate Release)
More informationCIGNA REPORTS STRONG FIRST QUARTER 2018 RESULTS, RAISES OUTLOOK. Shareholders net income for the first quarter was $915 million, or $3.
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG FIRST QUARTER 2018 RESULTS, RAISES OUTLOOK o o o o Total revenues
More informationBaird Global Healthcare Conference
Baird Global Healthcare Conference Jason Meggs Chief Financial Officer September 6, 2018 Forward-Looking Statements, Non-GAAP Financial Measures, and Basis of Financial Presentation Forward-Looking Statements
More informationTotal Premium Revenue (GAAP) ($ millions) $4,390.9 $3,578.8 Adjusted Premium Revenue (1) ($ millions) $4,361.4 $3,483.3
WELLCARE REPORTS THIRD QUARTER 2017 RESULTS COMPANY INCREASES FULL-YEAR 2017 GUIDANCE TAMPA, Fla. (Oct. 31, 2017) WellCare Health Plans, Inc. (NYSE: WCG) ( WellCare ) today reported results for the quarter
More informationCIGNA REPORTS STRONG FIRST QUARTER 2016 RESULTS, RAISES OUTLOOK. Shareholders net income for the first quarter was $519 million, or $2.
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG FIRST QUARTER 2016 RESULTS, RAISES OUTLOOK o o o Consolidated operating
More informationStanding strong for payers and patients
Standing strong for payers and patients Dr. Steve Miller, SVP, Chief Medical Officer Ben Bier, VP Investor Relations W I L L I A M B L A I R 3 7 TH ANNUAL G ROWTH STOCK C ONFERENCE 6.14.17 1 Safe harbor
More informationInvestor Presentation. March 2018
Investor Presentation March 2018 1 Forward-Looking Statements and Non-GAAP Measures This news release contains statements, estimates, or projections that constitute "forward-looking statements" as defined
More informationOur Transformation Continues. March 21, 2018
Our Transformation Continues March 21, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation, we make
More information2018 Guidance Conference Call
2018 Guidance Conference Call Dave Denton Executive Vice President & Chief Financial Officer January 4, 2018 Important Information for Investors and Shareholders No Offer or Solicitation Today's presentation
More informationDriving Profitable Growth
Driving Profitable Growth Frank Calderoni EVP and Chief Financial Officer December 7, 2012 Forward-Looking Statements This presentation contains projections and other forward-looking statements regarding
More information2017 WELLS FARGO HEALTHCARE CONFERENCE
2017 WELLS FARGO HEALTHCARE CONFERENCE September 7, 2017 TRANSFORMING HEALTHCARE TOGETHER UNIQUELY POSITIONED FOR THE FUTURE 2017 1 Craig McKasson Chief Financial Officer Premier Inc. TRANSFORMING HEALTHCARE
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More information(401) (212) FOR IMMEDIATE RELEASE CVS HEALTH REPORTS FOURTH QUARTER AND FULL YEAR RESULTS AND PROVIDES 2019 FULL YEAR GUIDANCE
Investor Mike McGuire Media T.J. Crawford Contact: Senior Vice President Contact: Vice President Investor Relations External Affairs (401) 770-4050 (212) 457-0583 FOR IMMEDIATE RELEASE CVS HEALTH REPORTS
More informationCIGNA REPORTS FIRST QUARTER 2012 RESULTS Raises Outlook for 2012 Earnings and Customer Growth
NEWS RELEASE Contact: Ted Detrick, Investor Relations (215) 761-1414 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS FIRST QUARTER 2012 RESULTS Raises Outlook for 2012 Earnings and Customer
More informationEarnings Presentation 2nd Quarter 2017
Earnings Presentation 2nd Quarter 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationEarnings Webcast & Conference Call. Fourth Quarter and Fiscal Year 2018
Earnings Webcast & Conference Call Fourth Quarter and Fiscal Year 2018 2017 1 Forward-Looking Statements This presentation and other written or oral statements made from time to time by representatives
More informationReducing Costs, Improving Quality, Reinventing Healthcare
Reducing Costs, Improving Quality, Reinventing Healthcare Investor Information January 2019 2018. All rights reserved. Premier Inc. Forward-looking statements and non-gaap financial measures Forward-looking
More informationQuad/Graphics, Inc. Call to Review Definitive Agreement to Acquire LSC Communications, Inc. and 3 rd Quarter 2018 Results.
Quad/Graphics, Inc. Call to Review Definitive Agreement to Acquire LSC Communications, Inc. and 3 rd Quarter 2018 Results October 31, 2018 Call Participants Joel Quadracci Chairman, President & Chief Executive
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION F O RWA R D L O O K I N G S TAT E M E N T S This presentation contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding
More information4th Quarter and Full Year 2011 Earnings Summary. February 14, 2012
4th Quarter and Full Year 2011 Earnings Summary February 14, 2012 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. federal securities laws.
More informationAETNA REPORTS SECOND-QUARTER 2018 RESULTS
151 Farmington Avenue Hartford, Conn. 06156 Media Contact: T.J. Crawford 212-457-0583 crawfordt2@aetna.com Investor Contact: Joe Krocheski 860-273-0896 krocheskij@aetna.com News Release AETNA REPORTS SECOND-QUARTER
More informationJP Morgan Healthcare Conference January 13, 2016
JP Morgan Healthcare Conference January 13, 2016 FORWARD-LOOKING STATEMENTS Certain statements and information in this presentation may be deemed to be forward-looking statements within the meaning of
More informationQ4 & Full Year FY2018 Financial Results. November 6, 2018
Q4 & Full Year FY2018 Financial Results November 6, 2018 Cautionary Note Regarding Forward-Looking Statements Certain of the statements contained in this presentation are forward-looking statements within
More informationLOOKING statements. Forward
1 Forward LOOKING statements This presentation contains forward-looking statements regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties.
More informationFourth Quarter 2015 Earnings Call February 11, 2016
Fourth Quarter 205 Earnings Call February, 206 Copyright 206 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements within the
More informationThird-Quarter 2012 Earnings Presentation
Third-Quarter 2012 Earnings Presentation Ursula Burns Chairman & CEO Luca Maestri Chief Financial Officer October 23, 2012 Forward-Looking Statements This presentation contains "forward-looking statements"
More informationN E W S R E L E A S E
N E W S R E L E A S E Investors: Brett Manderfeld John S. Penshorn Media: Tyler Mason Vice President Senior Vice President Vice President 952-936-7216 952-936-7214 424-333-6122 (For Immediate Release)
More informationFirst Quarter 2018 Financial Results. January 26, 2018
First Quarter 2018 Financial Results January 26, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationInvestor Overview Presentation. August 2018
Investor Overview Presentation August 2018 Forward-Looking Statements Statements about future results made in this presentation constitute forward-looking statements within the meaning of the Private Securities
More informationXYLEM INC. Q EARNINGS RELEASE FEBRUARY 1, 2018
XYLEM INC. Q4 2017 EARNINGS RELEASE FEBRUARY 1, 2018 Q4 2017 EARNINGS RELEASE FORWARD-LOOKING STATEMENTS This presentation contains information that may constitute forward-looking statements. Forward-looking
More informationCastlight Health. Investor Overview. John Doyle, CEO. January 2018 NYSE: CSLT
Castlight Health Investor Overview John Doyle, CEO January 2018 NYSE: CSLT 1 This presentation contains forward-looking statements regarding our trends, our strategies and the anticipated performance of
More informationSECOND QUARTER 2018 EARNINGS CALL. August 7, 2018
SECOND QUARTER 2018 EARNINGS CALL August 7, 2018 1 AGENDA AND SPEAKERS Joe Woody Chief Executive Officer V NOS Outlook Update on 2018 Priorities Steve Voskuil Chief Financial Officer Second Quarter Financial
More informationMyriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results
August 8, 2017 Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results Total Revenues of $200.5 Million Up 8 Percent GAAP Diluted EPS was $0.19 and Adjusted EPS of
More informationDST SYSTEMS, INC. March 2017
DST SYSTEMS, INC. March 2017 FORWARD LOOKING STATEMENTS Certain material presented in this presentation include forward-looking statements intended to qualify for the safe harbor from liability established
More informationCRANE CURRENCY ACQUISITION ANNOUNCEMENT CALL
CRANE CURRENCY ACQUISITION ANNOUNCEMENT CALL DECEMBER 6, 2017 1 Forward-Looking Statements - Disclaimer The information in this presentation includes forward-looking statements within the meaning of the
More informationN E W S R E L E A S E
N E W S R E L E A S E Investors: Brett Manderfeld John S. Penshorn Media: Tyler Mason Vice President Senior Vice President Vice President 952-936-7216 952-936-7214 424-333-6122 (For Immediate Release)
More informationEarnings. Larry Merlo. President & Chief Executive Officer. Executive Vice President & Chief Financial Officer. November 4, 2014
Third dquate Quarter Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 4, 2014 Forward-looking Statements
More informationFocus Financial Partners. Loring Ward to Merge with The Buckingham Family of Financial Services
Focus Financial Partners Loring Ward to Merge with The Buckingham Family of Financial Services September 27, 2018 Disclaimer Special Note Regarding Forward-Looking Statements Some of the information in
More informationAETNA REPORTS FOURTH-QUARTER AND FULL-YEAR 2013 RESULTS
151 Farmington Avenue Hartford, Conn. 06156 Media Contact: Cynthia Michener 860-273-8553 michenerc@aetna.com Investor Contact: Tom Cowhey 860-273-2402 cowheyt@aetna.com News Release AETNA REPORTS FOURTH-QUARTER
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationReconciliation of Non-GAAP Items Required by SEC Rules
2016 ACTUAL RESULTS CVS Health is providing non-gaap information that excludes certain items because of the nature of these items and the impact they have on the analysis of underlying business performance
More informationEarnings Presentation 4th Quarter, 2017
Earnings Presentation 4th Quarter, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationN E W S R E L E A S E
N E W S R E L E A S E Investors: Brett Manderfeld John S. Penshorn Media: Tyler Mason Vice President Senior Vice President Vice President 952-936-7216 952-936-7214 424-333-6122 (For Immediate Release)
More information